Henk Visscher
Princess Máxima Center(NL)
Publications by Year
Research Areas
Chemotherapy-induced cardiotoxicity and mitigation, Acute Lymphoblastic Leukemia research, Cancer therapeutics and mechanisms, Childhood Cancer Survivors' Quality of Life, Lung Cancer Research Studies
Most-Cited Works
- → Pharmacogenomic Prediction of Anthracycline-Induced Cardiotoxicity in Children(2011)392 cited
- → Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy(2009)326 cited
- → A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer(2015)270 cited
- → Efflux and Atherosclerosis(2003)239 cited
- → CAG Expansion in the Huntington Disease Gene Is Associated with a Specific and Targetable Predisposing Haplogroup(2009)238 cited
- → Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin(2011)200 cited
- → Validation of variants inSLC28A3andUGT1A6as genetic markers predictive of anthracycline‐induced cardiotoxicity in children(2013)196 cited
- → HTT haplotypes contribute to differences in Huntington disease prevalence between Europe and East Asia(2011)165 cited
- → Replication of TPMT and ABCC3 Genetic Variants Highly Associated With Cisplatin-Induced Hearing Loss in Children(2013)128 cited
- → Genetic Variants inSLC22A17 and SLC22A7are Associated With Anthracycline-Induced Cardiotoxicity in Children(2015)115 cited